Livagen
A short bioregulator peptide studied mostly in Russian laboratory research on aging cells.
- Type
- Short peptide (bioregulator)
- Research area
- Bioregulator peptides
- Research stage
- Laboratory research; limited clinical use outside the U.S.
- FDA status
- Not an FDA-approved medicine
About Livagen
A short bioregulator peptide studied mostly in Russian laboratory research on aging cells.
Where the research stands
Most published work on this compound comes from laboratory, animal or early human studies. Results in those settings don't always carry over to people, and long-term safety data are limited.
Read the studies
Educational information only; not medical advice. Talk to a licensed doctor before using any compound.
Related compounds
OvagenOvagen
A short bioregulator peptide studied mostly in Russian laboratory research related to liver tissue.
PancragenPancragen
A short bioregulator peptide studied mostly in Russian laboratory research related to the pancreas.
PinealonPinealon
A short bioregulator peptide studied mostly in Russian laboratory research related to nerve cells.